Related Experiment Videos
Apolipoprotein(a) gene enhancer resides within a LINE element
Z Yang1, D Boffelli, N Boonmark
1Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford, California 94305-5246, USA.
The Journal of Biological Chemistry
|February 14, 1998
Summary
Researchers discovered a novel gene enhancer element controlling apolipoprotein(a) [apo(a)] production. This element, found within a LINE retrotransposon, significantly boosts apo(a) gene transcription, offering new insights into cardiovascular disease risk factors.
Area of Science:
- Molecular Biology
- Genetics
- Cardiovascular Research
Background:
- Elevated plasma levels of apolipoprotein(a) [apo(a)] are a significant risk factor for cardiovascular disease.
- Understanding the transcriptional regulation of the apo(a) gene is crucial for developing therapeutic strategies.
Purpose of the Study:
- To identify and characterize enhancer elements that regulate the transcription of the human apo(a) gene.
- To investigate the potential role of retrotransposons in gene regulation.
Main Methods:
- Bioinformatic searches for regulatory elements upstream of the apo(a) gene.
- Functional analysis of identified elements using reporter gene assays in cultured hepatocyte cells.
- Sequence analysis to identify transcription factor binding sites.
Main Results:
- An upstream enhancer element was identified that significantly increases apo(a) gene promoter activity (over 10-fold).
- This enhancer contains binding sites for Ets and Sp1 nuclear proteins.
- The enhancer element is unexpectedly located within a LINE retrotransposon sequence.
Conclusions:
- LINE retrotransposons can harbor functional gene regulatory elements, suggesting a role in modulating the expression of nearby genes.
- The identified enhancer element provides a new target for understanding and potentially manipulating apo(a) levels, a key factor in cardiovascular disease risk.